US EditionPTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abeona Therapeutics granted 45,685 restricted shares to two new employees as a recruitment incentive, with shares vesting over three years, the company said.
- Abeona Therapeutics announced that its Compensation Committee on November 30, 2025 granted restricted stock awards to two newly hired non-executive employees, covering up to 45,685 restricted shares.
- The awards were granted as a material inducement to employment to recruit and incentivize two new hires, approved under Nasdaq Listing Rule 5635 by Abeona Therapeutics.
- The restricted awards fully vest after three years, subject to continued employment condition, with one-third annual vesting on each anniversary of the Grant Date.
- The announcement carried standard forward-looking disclaimers, including a forward-looking statements disclaimer with risks and uncertainties, and provided Greg Gin, VP, Investor Relations and Corporate Communications, at ir@abeonatherapeutics.com for inquiries.
- Abeona is a commercial-stage cell and gene therapy developer operating the Cleveland cGMP manufacturing facility, which produces ZEVASKYN, the first and only autologous cell-based gene therapy for RDEB.
17 Articles
17 Articles
The Daily News
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., Dec. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 24, 2025 , the company approved non-statutory stock options to purchase an aggregate of 2,000 shares of its common stock and 8,200 restricted…
Albuquerque Journal
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
MENLO PARK, Calif., Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted…
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Abeona Therapeutics (NASDAQ:ABEO)
CLEVELAND, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On November 30, 2025, the Compensation Committee of Abeona's Board of Directors granted restricted stock equity awards as a material inducement to employment to two individuals hired…
Coverage Details
Bias Distribution
- 87% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
